Skip to search formSkip to main contentSkip to account menu

Eloxatin

Known as: Eloxatine, Sanofi Synthelabo brand of oxaliplatin, Sanofi brand of oxaliplatin 
National Institutes of Health

Related topics

Related topics

2 relations
10 ML oxaliplatin 5 MG/ML Injection [Eloxatin]

Broader (1)

oxaliplatin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
A Pharmaco-Economic Analyzis of Treating Severe Uncontrolled Child Asthma with Omalizumab — Actual Russian Clinical Practice Data
Background: Omalizumab is the first and yet the only biopreparation for asthma which combines high efficiency and high cost. The… 
Highly Cited
2006
Highly Cited
2006
Raltitrexed–eloxatin salvage chemotherapy in gemcitabine-resistant metastatic pancreatic cancer
Limited information on salvage treatment in patients affected by pancreatic cancer is available. At failure, about half of the… 
Highly Cited
2006
Highly Cited
2006
Repression of cell cycle–related proteins by oxaliplatin but not cisplatin in human colon cancer cells
Oxaliplatin (Eloxatin) is a third-generation platinum derivative with an in vitro and in vivo spectrum of activity distinct from… 
2004
2004
Thermal enhancement of oxaliplatin-induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines
Hyperthermia is used to treat intraperitoneal colorectal carcinomatosis. In this setting, the molecular effects of oxaliplatin… 
2003
2003
Short-Time Infusion of Oxaliplatin (Eloxatin®) in Combination with Capecitabine (Xeloda®) in Patients with Advanced Colorectal Cancer
Neuropathy exacerbated by exposure to cold is a dose-limiting toxicity of oxaliplatin. The incidence of this side effect is… 
Review
2002
Review
2002
Cellular and molecular aspects of drugs of the future: oxaliplatin
Abstract. Oxaliplatin (Eloxatine) is a third-generation platinum compound which has shown a wide antitumour effect both in vitro… 
Review
2000
Review
2000
Oxaliplatin clinical activity: a review.
Highly Cited
2000
Highly Cited
2000
Validation of a highly sensitive ICP-MS method for the determination of platinum in biofluids: application to clinical pharmacokinetic studies with oxaliplatin.
Review
1998
Review
1998
Therapy for advanced colorectal cancer.
Although 5-fluorouracil (5-FU) has been used to treat advanced colorectal cancer for 45 years, the drug has only a modest… 
1997
1997
Addition of oxaliplatin (Eloxatine®, LOHP) to the same leucovorin (LV) and 5 fluorouracil (5FU) bimonthly regimens after progression in patients (pts) with metastatic colorectal cancer (MCRC…
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)